共 50 条
- [4] Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (16): : 1551 - 1560
- [5] Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: Long-term results from a phase 2/3 clinical trial JOURNAL OF DERMATOLOGY, 2012, 39 (03): : 242 - 252